Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

613 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI).
Gridelli C, D'Aprile M, Curcio C, Brancaccio L, Palmeri S, Comella G, Veltri E, Ferrante G, Gentile M, Rossi A, et al. Gridelli C, et al. Among authors: curcio c. Lung Cancer. 1994 Jul;11(1-2):83-91. doi: 10.1016/0169-5002(94)90285-2. Lung Cancer. 1994. PMID: 8081707 Clinical Trial.
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Comella P, Scoppa G, Daponte A, Musetta G, Anania C, Maiorino A, Curcio C, Casaretti R, Comella G. Comella P, et al. Among authors: curcio c. Cancer. 1994 Oct 1;74(7):1874-81. doi: 10.1002/1097-0142(19941001)74:7<1874::aid-cncr2820740708>3.0.co;2-u. Cancer. 1994. PMID: 8082093 Clinical Trial.
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
Gridelli C, Perrone F, D'Aprile M, Rossi A, Palmeri S, Curcio C, Veltri E, Ianniello G, Lorusso V, Palmieri G. Gridelli C, et al. Among authors: curcio c. Eur J Cancer. 1995 Dec;31A(13-14):2424-6. doi: 10.1016/0959-8049(95)00403-3. Eur J Cancer. 1995. PMID: 8652288 Clinical Trial. No abstract available.
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trial.
Comella P, Frasci G, Panza N, De Cataldis G, Cioffi R, Curcio C, Nicolella D, Micillo E, Ianniello GP, Biondi E, Perchard J, Comella G. Comella P, et al. Among authors: curcio c. Lung Cancer. 1996 Aug;15(1):103-14. doi: 10.1016/0169-5002(96)00575-2. Lung Cancer. 1996. PMID: 8865128 Clinical Trial.
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G. Comella P, et al. Among authors: curcio c. Br J Cancer. 1996 Dec;74(11):1805-11. doi: 10.1038/bjc.1996.634. Br J Cancer. 1996. PMID: 8956797 Free PMC article. Clinical Trial.
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.
Gridelli C, Perrone F, Ianniello GP, Brancaccio L, Iaffaioli RV, Curcio C, D'Aprile M, Cioffi R, Cigolari S, Rossi A, Palazzolo G, Veltri E, Pergola M, De Placido S, Gallo C, Monfardini S, Bianco AR. Gridelli C, et al. Among authors: curcio c. J Clin Oncol. 1998 Apr;16(4):1414-9. doi: 10.1200/JCO.1998.16.4.1414. J Clin Oncol. 1998. PMID: 9552045 Clinical Trial.
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Gridelli C, Curcio C, Iaffaioli RV, Brancaccio L, D'Aprile M, Gebbia V, Rossi A, Tortoriello A, Veltri E, Maione P, Barbarisi A, Gallo C, Guida C, Perrone F. Gridelli C, et al. Among authors: curcio c. Anticancer Res. 2001 Nov-Dec;21(6A):4179-83. Anticancer Res. 2001. PMID: 11911315 Clinical Trial.
613 results